Publication: Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation.
dc.contributor.author | Toro, Ayelén Rayen | |
dc.contributor.author | Maymó, Julieta Lorena | |
dc.contributor.author | Ibarbalz, Federico Matías | |
dc.contributor.author | Pérez Pérez, Antonio | |
dc.contributor.author | Maskin, Bernardo | |
dc.contributor.author | Faletti, Alicia Graciela | |
dc.contributor.author | Sánchez Margalet, Víctor | |
dc.contributor.author | Varone, Cecilia Laura | |
dc.contributor.authoraffiliation | [Toro,AR; Maymó,JL; Ibarbalz,FM; Varone,CL] Departamento de Química Biológica, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina. [Pérez Pérez,A; Sánchez Margalet,V] Departamento de Bioquímica Médica y Biología Molecular, Hospital Universitario Virgen Macarena, Facultad de Medicina, Universidad de Sevilla, Sevilla, España. [Maskin,B] Hospital Nacional Profesor Alejandro Posadas, Buenos Aires, Argentina. [Faletti,AG] Centro de Estudios Farmacológicos y Botánicos, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina. | es |
dc.contributor.funder | Grant Support: ART and JLM are supported by a CONICET fellowship. APP is a research fellow supported by the Instituto de Salud Carlos III (CM07/00025). This project was supported by the Universidad de Buenos Aires (UBACYT), the ANPCyT (PICT 2008-0425), the CONICET (PIP 2010-247), the Fundacio´n Florencio Fiorini, Buenos Aires, Argentina and the Instituto de Salud Carlos III (PS09/00119), Spain. | |
dc.date.accessioned | 2015-04-08T09:06:16Z | |
dc.date.available | 2015-04-08T09:06:16Z | |
dc.date.issued | 2014-06-12 | |
dc.description | Journal Article; Research Support, Non-U.S. Gov't; | es |
dc.description.abstract | Leptin, a peripheral signal synthetized by the adipocyte to regulate energy metabolism, can also be produced by placenta, where it may work as an autocrine hormone. We have previously demonstrated that leptin promotes proliferation and survival of trophoblastic cells. In the present work, we aimed to study the molecular mechanisms that mediate the survival effect of leptin in placenta. We used the human placenta choriocarcinoma BeWo and first trimester Swan-71 cell lines, as well as human placental explants. We tested the late phase of apoptosis, triggered by serum deprivation, by studying the activation of Caspase-3 and DNA fragmentation. Recombinant human leptin added to BeWo cell line and human placental explants, showed a decrease on Caspase-3 activation. These effects were dose dependent. Maximal effect was achieved at 250 ng leptin/ml. Moreover, inhibition of endogenous leptin expression with 2 µM of an antisense oligonucleotide, reversed Caspase-3 diminution. We also found that the cleavage of Poly [ADP-ribose] polymerase-1 (PARP-1) was diminished in the presence of leptin. We analyzed the presence of low DNA fragments, products from apoptotic DNA cleavage. Placental explants cultivated in the absence of serum in the culture media increased the apoptotic cleavage of DNA and this effect was prevented by the addition of 100 ng leptin/ml. Taken together these results reinforce the survival effect exerted by leptin on placental cells. To improve the understanding of leptin mechanism in regulating the process of apoptosis we determined the expression of different intermediaries in the apoptosis cascade. We found that under serum deprivation conditions, leptin increased the anti-apoptotic BCL-2 protein expression, while downregulated the pro-apoptotic BAX and BID proteins expression in Swan-71 cells and placental explants. In both models leptin augmented BCL-2/BAX ratio. Moreover we have demonstrated that p53, one of the key cell cycle-signaling proteins, is downregulated in the presence of leptin under serum deprivation. On the other hand, we determined that leptin reduced the phosphorylation of Ser-46 p53 that plays a pivotal role for apoptotic signaling by p53. Our data suggest that the observed anti-apoptotic effect of leptin in placenta is in part mediated by the p53 pathway. In conclusion, we provide evidence that demonstrates that leptin is a trophic factor for trophoblastic cells. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Toro AR, Maymó JL, Ibarbalz FM, Pérez Pérez A, Maskin B, Faletti AG, et al. Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation. 2014. PLoS ONE; 9(6):e99187 | es |
dc.identifier.doi | 10.1371/journal.pone.0099187 | |
dc.identifier.essn | 1932-6203 | |
dc.identifier.pmc | PMC4055782 | |
dc.identifier.pmid | 24922063 | |
dc.identifier.uri | http://hdl.handle.net/10668/1862 | |
dc.journal.title | PloS one | |
dc.language.iso | en | |
dc.publisher | Public Library of Science | es |
dc.relation.publisherversion | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099187 | es |
dc.rights.accessRights | open access | |
dc.subject | Leptina | es |
dc.subject | Placenta | es |
dc.subject | Coriocarcinoma | es |
dc.subject | Apoptosis | es |
dc.subject | Embarazo | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intracellular Signaling Peptides and Proteins::Apoptosis Regulatory Proteins::Proto-Oncogene Proteins c-bcl-2::BH3 Interacting Domain Death Agonist Protein | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Line::Cell Line, Tumor | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Down-Regulation | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Female | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Adipokines::Leptin | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Phosphorylation | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Amino Acids::Phosphoamino Acids::Phosphoserine | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Embryonic Structures::Placenta | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Pregnancy Complications, Infectious | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Endocrine Cells::Trophoblasts | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::DNA-Binding Proteins::Tumor Suppressor Protein p53 | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intracellular Signaling Peptides and Proteins::Apoptosis Regulatory Proteins::Proto-Oncogene Proteins c-bcl-2::bcl-2-Associated X Protein | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death::Apoptosis | es |
dc.title | Leptin is an anti-apoptotic effector in placental cells involving p53 downregulation. | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ToroAR_LeptinIsAnanti-apoptotic.pdf
- Size:
- 1.9 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo